{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T09:10:08Z","timestamp":1746868208131,"version":"3.40.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,10]]},"DOI":"10.7759\/cureus.83824","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T08:30:26Z","timestamp":1746865826000},"source":"Crossref","is-referenced-by-count":0,"title":["Low-Dose Naltrexone for Severe Fibromyalgia Syndrome: A Report of a Case With Two-Year Follow-Up"],"prefix":"10.7759","author":[{"given":"Ulrich","family":"Moser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12061266","article-title":"Management of fibromyalgia: an update","volume":"12","author":"Jones EA","year":"2024","unstructured":"Jones EA, Asaad F, Patel N, Jain E, Abd-Elsayed A. Management of fibromyalgia: an update. Biomedicines. 2024, 12:1266. 10.3390\/biomedicines12061266","journal-title":"Biomedicines"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60020272","article-title":"Unraveling the complex web of fibromyalgia: a narrative review","volume":"60","author":"Al Sharie S","year":"2024","unstructured":"Al Sharie S, Varga SJ, Al-Husinat L, Sarzi-Puttini P, Araydah M, Bal'awi BR, Varrassi G. Unraveling the complex web of fibromyalgia: a narrative review. Medicina (Kaunas). 2024, 60:272. 10.3390\/medicina60020272","journal-title":"Medicina (Kaunas)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.211170","article-title":"Microstructural evidence of neuroinflammation for psychological symptoms and pain in patients with fibromyalgia","volume":"49","author":"Lo YC","year":"2022","unstructured":"Lo YC, Li TJ, Lin TC, Chen YY, Kang JH. Microstructural evidence of neuroinflammation for psychological symptoms and pain in patients with fibromyalgia. J Rheumatol. 2022, 49:942-7. 10.3899\/jrheum.211170","journal-title":"J Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-230","article-title":"Neuronal toll-like receptor 4 signaling induces brain endothelial activation and neutrophil transmigration in vitro","volume":"9","author":"Leow-Dyke S","year":"2012","unstructured":"Leow-Dyke S, Allen C, Denes A, et al.. Neuronal toll-like receptor 4 signaling induces brain endothelial activation and neutrophil transmigration in vitro. J Neuroinflammation. 2012, 9:230. 10.1186\/1742-2094-9-230","journal-title":"J Neuroinflammation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06229-5","article-title":"Nociplastic pain concept, a mechanistic basis for pragmatic approach to fibromyalgia","volume":"41","author":"Bidari A","year":"2022","unstructured":"Bidari A, Ghavidel-Parsa B. Nociplastic pain concept, a mechanistic basis for pragmatic approach to fibromyalgia. Clin Rheumatol. 2022, 41:2939-47. 10.1007\/s10067-022-06229-5","journal-title":"Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-8-27","article-title":"An internet survey of 2,596 people with fibromyalgia","volume":"8","author":"Bennett RM","year":"2007","unstructured":"Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007, 8:27. 10.1186\/1471-2474-8-27","journal-title":"BMC Musculoskelet Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.118810","article-title":"Different effects of opioid antagonists on \u03bc-, \u03b4-, and \u03ba-opioid receptors with and without agonist pretreatment","volume":"321","author":"Wang D","year":"2007","unstructured":"Wang D, Sun X, Sadee W. Different effects of opioid antagonists on \u03bc-, \u03b4-, and \u03ba-opioid receptors with and without agonist pretreatment. J Pharmacol Exp Ther. 2007, 321:544-52. 10.1124\/jpet.106.118810","journal-title":"J Pharmacol Exp Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2517-2","article-title":"The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain","volume":"33","author":"Younger J","year":"2014","unstructured":"Younger J, Parkitny L, McLain D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol. 2014, 33:451-9. 10.1007\/s10067-014-2517-2","journal-title":"Clin Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.34.1.1","article-title":"Low-dose naltrexone in rheumatological diseases","volume":"34","author":"de Carvalho JF","year":"2023","unstructured":"de Carvalho JF, Skare T. Low-dose naltrexone in rheumatological diseases. Mediterr J Rheumatol. 2023, 34:1-6. 10.31138\/mjr.34.1.1","journal-title":"Mediterr J Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aen103","article-title":"Assessment of pain","volume":"101","author":"Breivik H","year":"2008","unstructured":"Breivik H, Borchgrevink PC, Allen SM, et al.. Assessment of pain. Br J Anaesth. 2008, 101:17-24. 10.1093\/bja\/aen103","journal-title":"Br J Anaesth"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe F","year":"2016","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, et al.. 2016 revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016, 46:319-29. 10.1016\/j.semarthrit.2016.08.012","journal-title":"Semin Arthritis Rheum"},{"key":"ref12","article-title":"Categorisation of disease severity states in fibromyalgia: a first step to support decision-making in health care policy","volume":"36","author":"Salaffi F","year":"2018","unstructured":"Salaffi F, Di Carlo M, Arc\u00e0 S, Galeazzi M. Categorisation of disease severity states in fibromyalgia: a first step to support decision-making in health care policy. Clin Exp Rheumatol. 2018, 36:1074-81.","journal-title":"Clin Exp Rheumatol"},{"key":"ref13","article-title":"An ultra-brief screening scale for anxiety and depression: the PHQ-4","volume":"50","author":"Kroenke K","year":"2009","unstructured":"Kroenke K, Spitzer RL, Williams JB, L\u00f6we B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009, 50:613-21.","journal-title":"Psychosomatics"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.21801\/ppcrj.2023.93.2","article-title":"Physical conditioning, obesity and fibromyalgia: causal relationship or confounding?","volume":"9","author":"Costa V","year":"2023","unstructured":"Costa V, Gianloren\u00e7o AC, Daibes M, et al.. Physical conditioning, obesity and fibromyalgia: causal relationship or confounding?. Princ Pract Clin Res. 2023, 9:63-8. 10.21801\/ppcrj.2023.93.2","journal-title":"Princ Pract Clin Res"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.5152\/cjm.2022.22124","article-title":"Investigating fibromyalgia in sarcoidosis patients","volume":"47","author":"Atahan E","year":"2023","unstructured":"Atahan E, \u00c7al\u0131\u015fkaner \u00d6zt\u00fcrk B, Y\u0131ld\u0131z P, Asaoglu \u0130, M\u00fcsellim B. Investigating fibromyalgia in sarcoidosis patients. Cerrahpa\u015fa Med J. 2023, 47:14-8.","journal-title":"Cerrahpa\u015fa Med J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-002-0279-7","article-title":"Fibromyalgia in diabetes mellitus","volume":"23","author":"Tishler M","year":"2003","unstructured":"Tishler M, Smorodin T, Vazina-Amit M, Ramot Y, Koffler M, Fishel B. Fibromyalgia in diabetes mellitus. Rheumatol Int. 2003, 23:171-3. 10.1007\/s00296-002-0279-7","journal-title":"Rheumatol Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1394865","article-title":"Fibromyalgia in obstructive sleep apnea-hypopnea syndrome: a systematic review and meta-analysis","volume":"15","author":"He J","year":"2024","unstructured":"He J, Chen M, Huang N, Wang B. Fibromyalgia in obstructive sleep apnea-hypopnea syndrome: a systematic review and meta-analysis. Front Physiol. 2024, 15:1394865. 10.3389\/fphys.2024.1394865","journal-title":"Front Physiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines5020016","article-title":"Reduced pro-inflammatory cytokines after eight weeks of low-dose naltrexone for fibromyalgia","volume":"5","author":"Parkitny L","year":"2017","unstructured":"Parkitny L, Younger J. Reduced pro-inflammatory cytokines after eight weeks of low-dose naltrexone for fibromyalgia. Biomedicines. 2017, 5:16. 10.3390\/biomedicines5020016","journal-title":"Biomedicines"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3344\/kjp.24202","article-title":"Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis","volume":"37","author":"Vatvani AD","year":"2024","unstructured":"Vatvani AD, Patel P, Hariyanto TI, Yanto TA. Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. Korean J Pain. 2024, 37:367-78. 10.3344\/kjp.24202","journal-title":"Korean J Pain"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/366372-low-dose-naltrexone-for-severe-fibromyalgia-syndrome-a-report-of-a-case-with-two-year-follow-up","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T08:30:27Z","timestamp":1746865827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/366372-low-dose-naltrexone-for-severe-fibromyalgia-syndrome-a-report-of-a-case-with-two-year-follow-up"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.83824","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,10]]}}}